Project EORTC-1301-LG – 1301-LG

Basic data

Acronym:
EORTC-1301-LG
Title:
1301-LG
Duration:
01/05/2015 to 31/12/2022
Abstract / short description:
"10-day decitabine versus conventional chemotherapy (“3+7”)
followed by allografting in AML patients ≥ 60 years: a
randomized phase III study of the EORTC Leukemia Group,
CELG, GIMEMA and German MDS Study Group [AML-21]"
Keywords:
AML
>= 60 Jahre

Involved staff

Managers

Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Help

will be deleted permanently. This cannot be undone.